Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
51.89
-1.75 (-3.26%)
At close: Jan 17, 2025, 4:00 PM
52.00
+0.11 (0.21%)
After-hours: Jan 17, 2025, 4:36 PM EST
Verona Pharma Employees
Verona Pharma had 79 employees as of December 31, 2023. The number of employees increased by 43 or 119.44% compared to the previous year.
Employees
79
Change (1Y)
43
Growth (1Y)
119.44%
Revenue / Employee
$71,190
Profits / Employee
-$1,945,861
Market Cap
4.25B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
VRNA News
- 12 days ago - Verona Pharma's Ohtuvayre Defies Expectations In Q4, But Stock Alpha May Now Be Limited - Seeking Alpha
- 13 days ago - Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights - GlobeNewsWire
- 2 months ago - Verona Pharma Announces December 2024 Investor Conference Participation - GlobeNewsWire
- 2 months ago - Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value - CNBC
- 2 months ago - Verona Pharma to Present at Jefferies London Healthcare Conference - GlobeNewsWire
- 2 months ago - Verona Pharma plc (VRNA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update - GlobeNewsWire